Imagen de Portada

Differential Response and Resistance to KRAS‐Targeted Therapy

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhaojin Liu, Heinz‐Josef Lenz, Jian Yu, Lin Zhang
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Molecular Carcinogenesis
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Targeting Posttranslational Modifications in the Tumor Stromal Microenvironment for Antitumor Therapy
por: Huiguo Qing, et al.
Publicado: (2025)

Case report & review: Bilateral NIFTP harboring concomitant HRAS and KRAS mutation: Report of an unusual case and literature review
por: Marianna Rita Brogna, et al.
Publicado: (2024)

microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2
por: Qing Xia, et al.
Publicado: (2024)

HGF/c‐Met Promotes Breast Cancer Tamoxifen Resistance Through the EZH2/HOTAIR‐miR‐141/200a Feedback Signaling Pathway
por: Xiaofeng Lai, et al.
Publicado: (2025)

MicroRNA‐505‐5p/‐3p Regulates the Proliferation, Invasion, Apoptosis, and Temozolomide Resistance in Mesenchymal Glioma Stem Cells by Targeting AUF1
por: Souichi Oe, et al.
Publicado: (2024)

Pregnane X Receptor Activation Induces Ferroptosis Resistance Through Upregulation of FSP1
por: Yingying Shang, et al.
Publicado: (2025)

β‐Elemene Inhibits Adrenocortical Carcinoma Cell Proliferation and Migration, and Induces Apoptosis by Up‐Regulating miR‐486‐3p/Targeting NPTX1 Axis
por: Yan Lin, et al.
Publicado: (2025)

Venetoclax Synergizes With Regorafenib for Colorectal Cancer by Targeting BCL‐2
por: Lijun Zhu, et al.
Publicado: (2025)

ZNF480 Accelerates Chemotherapy Resistance in Breast Cancer by Competing With TRIM28 and Stabilizing LSD1 to Upregulate the AKT‐GSK3β‐Snail Pathway
por: Xiaowen Ma, et al.
Publicado: (2024)

Protein Kinase Inhibitor Alpha Drives Vincristine Resistance in Ewing Sarcoma via cAMP–EPAC Signaling Reprogramming
por: Xin Zhou, et al.
Publicado: (2025)

Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Mengqiu Song, et al.
Publicado: (2024)

LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma
por: Yifan Wen, et al.
Publicado: (2026)

Targeting TROP2 and Exploiting AUNIP as a Determinant of ADC Cytotoxicity and Chemosensitivity in HNSCC and ESCA Cancers
por: Jiaqi Bai, et al.
Publicado: (2026)

KIF4A Inhibits Ferroptosis in Glioblastoma via the CHMP4B/GPX4 Axis and Promotes Temozolomide Resistance
por: Xinan Shen, et al.
Publicado: (2025)

HMGB3 Contributes to Anti‐PD‐1 Resistance by Inhibiting IFN‐γ‐Driven Ferroptosis in TNBC
por: Bo Luo, et al.
Publicado: (2024)

Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy
por: Xing Ma, et al.
Publicado: (2024)

AN02, a Naovel Curcumin Derivative, Orchestrates APC‐SMAD4‐Mediated CTLA‐4 Degradation for Ovarian Cancer Therapy
por: Hairong Jin, et al.
Publicado: (2025)

USP15 Promotes Pancreatic Cancer Progression and Cisplatin Resistance By Activating DNA Damage Repair
por: Zhigang Ma, et al.
Publicado: (2026)

Identification of a Novel RUNX1::HMGN1 Fusion in Therapy Acute Myeloid Leukemia
por: Li Fen, et al.
Publicado: (2025)

miR‐135b‐5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial‐Mesenchymal Transition
por: Yuxuan Fu, et al.
Publicado: (2025)

CRISPR‐Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer
por: Shawn Noronha, et al.
Publicado: (2026)

CYP4F11, an NRF2 Target Gene, Promotes Hepatocellular Carcinoma Cell Growth
por: Jinjing Chen, et al.
Publicado: (2025)

Integrated Genomics Reveal Potential Resistance Mechanisms of PANoptosis‐Associated Genes in Acute Myeloid Leukemia
por: Cong Liang, et al.
Publicado: (2025)

RNF7‐Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes
por: Yiran Tao, et al.
Publicado: (2025)

Therapeutic Targeting of the Pentose Phosphate Pathway in Colorectal Cancer Using 6‐Aminonicotinamide and 5‐Fluorouracil
por: Israa Ahmad Cheikh, et al.
Publicado: (2025)

Integrated Analysis Reveals ZNF184 as a Novel Regulator of Stemness‐Associated Paclitaxel Resistance and Tumor Progression in Breast Cancer
por: Rong Gong, et al.
Publicado: (2026)

Targeting FGFR Attenuates Tumor Growth in an Anal Squamous Cell Carcinoma Patient Derived Xenograft Model
por: Thuc Ly, et al.
Publicado: (2025)

AOC3 Loss Promotes Imatinib Resistance in GIST by Stabilizing HK2 and Enhancing H3K18la‐Driven Myc Transcription
por: Zhiyuan Guo, et al.
Publicado: (2026)

Zinc Finger Protein 263 Augments Autophagy and Promotes Intrahepatic Cholangiocarcinoma Proliferation
por: Zaihua Yan, et al.
Publicado: (2024)

FAM162A Promotes Osteosarcoma Progression Via Activating HIF‐1α to Enhance Glycolysis
por: Jun Zhang, et al.
Publicado: (2026)

PTPN2 Expression in Hypopharyngeal Squamous Cell Carcinoma and Its Clinical Significance
por: Xue Li, et al.
Publicado: (2025)

Withaferin A Exerts Cytotoxicity in Single/Multidrug‐Resistant Gastric and Ovarian Cancer Cells and Tumor Xenografts Through the AKT–NF‐κB–STAT3–Survivin Axis
por: Priti S. Shenoy, et al.
Publicado: (2025)

Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition
por: Fangquan Chen, et al.
Publicado: (2024)

Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B
por: Qianjin Zhang, et al.
Publicado: (2024)

Elucidating the Mechanism of 1,4,5,6,7,8‐Hexahydropyrido[4,3‐d]Pyrimidine‐Induced Inhibition of Glioma Growth Through miR‐873‐3p
por: Hongyu Zhang, et al.
Publicado: (2025)

Prevalence of Molecular Subtypes of Gastric Cancer in Taiwan and the Impact of High SLC25A22 Expression on Survival: A Single‐Center Experience
por: Yu‐Ting Lee, et al.
Publicado: (2026)

miR‐150‐5p Regulates Merkel Cell Carcinoma Progression by Targeting FTO That Stabilizes CTNNB1 via m6A Modification
por: Bin Zheng, et al.
Publicado: (2025)

EphA2/SHP2/SOX8 Axis: A Novel Target for Regulation of Migration and Cetuximab Treatment Sensitivity in Oral Squamous Cell Carcinoma
por: Dayong Yan, et al.
Publicado: (2026)

Downregulation of ESRP2 Promotes Breast Cancer Cell Migration by Activating EMT Transcription Program Through Modulation of ENAH Variable Splicing
por: Yuting Chen, et al.
Publicado: (2026)

P21‐Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells
por: Swetha Rajendran, et al.
Publicado: (2025)